1-anilino-8-naphthalenesulfonate has been researched along with Fecal Incontinence in 1 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Fecal Incontinence: Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Orlistat could be a useful adjunct in the treatment of severe obesity in adolescents; however, gastrointestinal side-effects limit its usefulness in almost one in three adolescents." | 9.11 | Addition of orlistat to conventional treatment in adolescents with severe obesity. ( Bereket, A; Keskin, S; Ozkan, B; Turan, S, 2004) |
| "Orlistat could be a useful adjunct in the treatment of severe obesity in adolescents; however, gastrointestinal side-effects limit its usefulness in almost one in three adolescents." | 5.11 | Addition of orlistat to conventional treatment in adolescents with severe obesity. ( Bereket, A; Keskin, S; Ozkan, B; Turan, S, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozkan, B | 1 |
| Bereket, A | 1 |
| Turan, S | 1 |
| Keskin, S | 1 |
1 trial available for 1-anilino-8-naphthalenesulfonate and Fecal Incontinence
| Article | Year |
|---|---|
Addition of orlistat to conventional treatment in adolescents with severe obesity.
Topics: Adolescent; Anti-Obesity Agents; Body Mass Index; Caloric Restriction; Child; Combined Modality Ther | 2004 |